NASDAQ:RMTI - Rockwell Medical Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$4.78 -0.04 (-0.83 %)
(As of 05/24/2019 01:28 AM ET)
Previous Close$4.82
Today's Range$4.66 - $4.81
52-Week Range$2.19 - $6.88
Volume159,452 shs
Average Volume300,720 shs
Market Capitalization$275.16 million
P/E RatioN/A
Dividend YieldN/A
Beta2
Rockwell Medical, Inc. operates as a specialty pharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis. The company offers Triferic, an iron therapy that replaces iron and maintains hemoglobin in dialysis patients without increasing iron stores; and Calcitriol, an active vitamin D injection for the management of hypocalcemia in patients undergoing chronic hemodialysis. It is also developing an intravenous formulation of Triferic for use by hemodialysis patients. In addition, the company manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, RenalPure powder bicarbonate concentrate, and SteriLyte liquid bicarbonate concentrate; and ancillary products, including blood tubing, fistula needles, dialyzers, drugs, specialized component kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers. Its dialysis concentrate products are used to maintain human life by removing toxins and replacing critical nutrients in the dialysis patient's bloodstream. Rockwell Medical, Inc. sells its products directly, as well as through independent sales agents and distributors. Its target customers include senior and operating management of dialysis companies, dialysis service providers, nephrologists, clinic administrators, nurses, medical directors, and technical and purchasing personnel. Rockwell Medical, Inc. was founded in 1994 and is based in Wixom, Michigan.

Receive RMTI News and Ratings via Email

Sign-up to receive the latest news and ratings for RMTI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryHealth Care Equipment
SectorMedical
Current SymbolNASDAQ:RMTI
CUSIP77437410
Phone248-960-9009

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$63.39 million
Book Value$0.35 per share

Profitability

Net Income$-32,130,000.00

Miscellaneous

Employees269
Market Cap$275.16 million
Next Earnings Date8/13/2019 (Estimated)
OptionableOptionable

Rockwell Medical (NASDAQ:RMTI) Frequently Asked Questions

What is Rockwell Medical's stock symbol?

Rockwell Medical trades on the NASDAQ under the ticker symbol "RMTI."

How were Rockwell Medical's earnings last quarter?

Rockwell Medical Inc (NASDAQ:RMTI) released its quarterly earnings results on Thursday, May, 9th. The company reported ($0.15) earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of ($0.18) by $0.03. The company had revenue of $15.56 million for the quarter, compared to analysts' expectations of $16.90 million. Rockwell Medical had a negative net margin of 55.09% and a negative return on equity of 144.07%. View Rockwell Medical's Earnings History.

When is Rockwell Medical's next earnings date?

Rockwell Medical is scheduled to release their next quarterly earnings announcement on Tuesday, August 13th 2019. View Earnings Estimates for Rockwell Medical.

What price target have analysts set for RMTI?

2 equities research analysts have issued 12-month target prices for Rockwell Medical's shares. Their predictions range from $11.00 to $11.00. On average, they expect Rockwell Medical's share price to reach $11.00 in the next year. This suggests a possible upside of 130.1% from the stock's current price. View Analyst Price Targets for Rockwell Medical.

What is the consensus analysts' recommendation for Rockwell Medical?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Rockwell Medical in the last year. There are currently 1 buy rating and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Strong Buy." View Analyst Ratings for Rockwell Medical.

Has Rockwell Medical been receiving favorable news coverage?

Press coverage about RMTI stock has trended somewhat positive on Friday, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Rockwell Medical earned a news sentiment score of 1.9 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the company's share price in the next few days.

Who are some of Rockwell Medical's key competitors?

What other stocks do shareholders of Rockwell Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Rockwell Medical investors own include JinkoSolar (JKS), Immunomedics (IMMU), Seattle Genetics (SGEN), Iovance Biotherapeutics (IOVA), Portola Pharmaceuticals (PTLA), Davita (dva), Gilead Sciences (GILD), Heron Therapeutics (HRTX), ImmunoGen (IMGN) and JAKKS Pacific (JAKK).

Who are Rockwell Medical's key executives?

Rockwell Medical's management team includes the folowing people:
  • Mr. Stuart Paul, Pres, CEO & Director (Age 59)
  • Mr. Angus W. Smith, Chief Financial Officer (Age 36)
  • Dr. Ajay Gupta, Chief Scientific Officer & Member of Scientific Advisory Board (Age 61)
  • Mr. Michael DeYoung, VP of Operations
  • Mr. David J. Kull, Principal Accounting Officer, Sec. & Controller (Age 51)

Who are Rockwell Medical's major shareholders?

Rockwell Medical's stock is owned by a number of of institutional and retail investors. Top institutional investors include BlackRock Inc. (5.66%), Northern Trust Corp (1.10%), Geode Capital Management LLC (1.09%), Perkins Capital Management Inc. (0.78%), BKS Advisors LLC (0.39%) and Morgan Stanley (0.28%). View Institutional Ownership Trends for Rockwell Medical.

Which institutional investors are selling Rockwell Medical stock?

RMTI stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley, Virtu Financial LLC and Envestnet Asset Management Inc.. View Insider Buying and Selling for Rockwell Medical.

Which institutional investors are buying Rockwell Medical stock?

RMTI stock was acquired by a variety of institutional investors in the last quarter, including Geode Capital Management LLC, Parametric Portfolio Associates LLC, Corient Capital Partners LLC, Renaissance Technologies LLC, MetLife Investment Advisors LLC, MetLife Investment Advisors LLC, Perkins Capital Management Inc. and Valeo Financial Advisors LLC. View Insider Buying and Selling for Rockwell Medical.

How do I buy shares of Rockwell Medical?

Shares of RMTI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Rockwell Medical's stock price today?

One share of RMTI stock can currently be purchased for approximately $4.78.

How big of a company is Rockwell Medical?

Rockwell Medical has a market capitalization of $275.16 million and generates $63.39 million in revenue each year. The company earns $-32,130,000.00 in net income (profit) each year or ($0.47) on an earnings per share basis. Rockwell Medical employs 269 workers across the globe.

What is Rockwell Medical's official website?

The official website for Rockwell Medical is http://www.rockwellmed.com/.

How can I contact Rockwell Medical?

Rockwell Medical's mailing address is 30142 S WIXOM RD, WIXOM MI, 48393. The company can be reached via phone at 248-960-9009 or via email at [email protected]


MarketBeat Community Rating for Rockwell Medical (NASDAQ RMTI)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  240 (Vote Outperform)
Underperform Votes:  273 (Vote Underperform)
Total Votes:  513
MarketBeat's community ratings are surveys of what our community members think about Rockwell Medical and other stocks. Vote "Outperform" if you believe RMTI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RMTI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 5/24/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel